References: 1. BIAH studies #2013200, 2013232, and 2014001 published on
http://productdata.aphis.usda.gov. 2. Genzow M, Goodell C, Kaiser TJ, Johnson W, Eichmeyer M. Live attenuated influenza virus vaccine reduces virus shedding of newborn piglets in the presence of maternal antibody. Influenza Other Respir Viruses. 2017;00:1–7. doi:10.1111/irv.12531. 3. Alvarez J, Sarradell J, Kerkaert B, et al. Association of the
influenza A virus and porcine reproductive and respiratory syndrome virus in sow farms with post-weaning
mortality. Prev Vet Med. 2015;121:240–245. 4. Vincent AL, Ma W, Lager KM, et al. Efficacy
administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine.
2007;25:7999–8009. 5. Janke BH. Influenza A virus infections in swine: pathogenesis and
diagnosis. Vet Pathol. 2014;51:410–426.
Are you located within the United States of America?
ARE YOU A VETERINARIAN?
This is a required field
This website is an international information resource intended for veterinarians who are interested in
information about Ingelvac Provenza® and influenza A virus in swine.
While the Internet serves a global community, the pharmaceutical industry is subject to country-specific
regulatory considerations. This means that the registration status and approved product label may not be
the same in different countries.
INGELVAC Provenza® IS ONLY CURRENTLY LICENCED IN THE UNITED STATES OF AMERICA. Information on this website
is derived from the product label in the USA.
By checking the box below, you are declaring and confirming that you are a veterinarian professional and that you have read and understood this disclaimer.
You must accept the terms and conditions and data policy to enter the website